Rhythm

BioSig Expands its Installation Base in Texas

Signs a new installation agreement with high-volume center in San Antonio Westport, CT, Nov. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]

Peerbridge Health and BetterNight partnership addresses unmet need in AFib and Sleep Apnea Coordinated Care

A unique new care management solution will accelerate diagnosis and treatment of AFib and sleep apnea patients in cardiology practices NEW YORK, Nov. 3, 2021 /PRNewswire/ — Peerbridge Health and BetterNight are partnering on a unique new care management solution designed specifically for cardiology practices for earlier  identification, treatment, and optimization of […]

VUNO Med®-DeepECG™ Designated as Breakthrough Device

SEOUL, South Korea, Nov. 2, 2021 /PRNewswire/ — South Korean artificial intelligence (AI) developer, VUNO inc. announced that the Korean Ministry of Food and Drug Safety (KFDA) has designated the company’s artificial intelligence-based electrocardiogram (ECG) analysis software VUNO Med®-DeepECG™ as the ministry’s 16th Breakthrough Device. Using deep learning, the software analyzes ECG data […]

BioSig Increases Case Volume Estimates

The Company reports increased adoption and commercial activity of its signal processing technology for arrhythmia care Westport, CT, Nov. 01, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover […]

MemorialCare Saddleback Medical Center Marks Major Milestone with Successful 100th WATCHMAN™ Atrial Appendage Closure Device Procedure for Laguna Woods Village Resident Suffering from Atrial Fibrillation

The permanent heart implant is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation LAGUNA HILLS, CA – Oct. 28, 2021 — The MemorialCare Heart & Vascular Institute at Saddleback Medical Center recently performed its 100th WATCHMAN™ Left Atrial Appendage Closure Device procedure, […]

EBR Systems’ WiSE CRT System Demonstrates Technical Feasibility of Leadless Left Bundle Branch Area Pacing for Cardiac Resynchronization

New Case Report Reveals Opportunity to Become First-Line Therapy for Patients SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating the WiSE™ CRT System’s ability to successfully deliver leadless Left Bundle Branch Area Pacing […]

IMPULSE DYNAMICS RECEIVES FDA APPROVAL TO MODIFY LABELING FOR OPTIMIZER SMART MEDICAL DEVICES

FDA Authorizes Removal of “NSR” From Indications for Use MARLTON, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the U.S. Food and Drug Administration approved a modification of labeling for […]

RapidDeploy and PulsePoint Partner to Increase Cardiac Arrest Survivability

The third and latest RapidDeploy and PulsePoint integration provides community AED locations on RapidDeploy maps to provide telecommunicators visibility to nearby AEDs as part of the 9-1-1 workflow. AUSTIN, Texas, Oct. 26, 2021 /PRNewswire/ — Today RapidDeploy, the industry’s leading cloud-native emergency response platform, announces a new free integration with PulsePoint, a nonprofit whose […]

CathVision Announces First Patient Enrollments in PVISION Multicenter Clinical Study

Researchers to Examine Efficacy of Using AI Algorithm to Confirm Pulmonary Vein Isolation COPENHAGEN, Denmark and MINNETONKA, Minn., Oct. 26, 2021 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions in EP recording technology, today announced the first patient enrollments in the PVISION multicenter clinical study. The newly launched trial will investigate the […]